Scientists have used a "kidney on a chip" device to mimic the flow of medication through human kidneys, a technique that may lead to more precise dosing of drugs, including some toxic medicines used in ICU. Precise dosing in intensive care units (ICU) is critical, as up to two-thirds of patients in the ICU experience serious kidney injury.
Renal cells and nephrons have already been simulated by microfluidic devices. "Such cell cultures can lead to new insights into cell and organ function and be used for drug screening". A kidney-on-a-chip device has the potential to accelerate research encompassing artificial replacement for lost kidney function. Nowadays, dialysis requires patients to go to a clinic up to three times per week. A more transportable and accessible form of treatment would not only increase the patient’s overall health (by increasing frequency of treatment), but the whole process would become more efficient and tolerable. Artificial kidney research is striving to bring transportability, wearability and perhaps implantation capability to the devices through innovative disciplines: microfluidics, miniaturization and nanotechnology.

In 2021, the global Kidney-on-a-chip market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Kidney-on-a-chip status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Kidney-on-a-chip development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Kidney-on-a-chip Scope and Market Size
Kidney-on-a-chip market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney-on-a-chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Child Kidney-on-a-chip
Adult Kidney-on-a-chip

Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.